Should JAK2V617F Allele Burden Be Monitored in Patients with PV?
Dr. Ruben Mesa, Mayo Clinic, answers the following question: Should JAK2V617F allele burden be monitored in patients with PV?
Recent Video
Most Popular
Specialties :                    Search : is a member of the Oncology.TV family of oncology medical education websites. offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).